Mary Laughlin

2.0k total citations · 1 hit paper
28 papers, 1.5k citations indexed

About

Mary Laughlin is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Mary Laughlin has authored 28 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 13 papers in Genetics and 7 papers in Immunology. Recurrent topics in Mary Laughlin's work include Hematopoietic Stem Cell Transplantation (14 papers), Mesenchymal stem cell research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Mary Laughlin is often cited by papers focused on Hematopoietic Stem Cell Transplantation (14 papers), Mesenchymal stem cell research (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Mary Laughlin collaborates with scholars based in United States, France and Canada. Mary Laughlin's co-authors include Joanne Kurtzberg, Edward C. Halperin, Cladd E. Stevens, Clay Smith, Janice F. Olson, Michael L. Graham, Carmelita Carrier, Pablo Rubinstein, Nelson J. Chao and John E. Wagner and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mary Laughlin

27 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipients

1996 762 citations Joanne Kurtzberg, Mary Laughlin et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Laughlin United States	12	1.1k	575	390	360	232	28	1.5k
Mei Jie Zhang China	7	1.1k 1.0×	422 0.7×	378 1.0×	294 0.8×	170 0.7×	15	1.4k
Jan Maciej Zaucha Poland	20	757 0.7×	374 0.7×	448 1.1×	443 1.2×	258 1.1×	137	1.7k
Steven Neudorf United States	21	1.0k 0.9×	280 0.5×	265 0.7×	239 0.7×	256 1.1×	40	1.4k
Gitte Kerndrup Denmark	27	1.5k 1.4×	433 0.8×	299 0.8×	197 0.5×	638 2.8×	71	2.1k
NG Testa United Kingdom	23	1.5k 1.4×	608 1.1×	520 1.3×	591 1.6×	388 1.7×	65	2.1k
J. Mittermüller Germany	16	1.3k 1.2×	311 0.5×	858 2.2×	637 1.8×	219 0.9×	35	2.0k
Mario Sessarego Italy	28	1.8k 1.7×	882 1.5×	316 0.8×	387 1.1×	425 1.8×	122	2.3k
Rik Schots Belgium	24	779 0.7×	228 0.4×	416 1.1×	403 1.1×	541 2.3×	63	1.5k
Ely Benaim United States	21	445 0.4×	218 0.4×	320 0.8×	412 1.1×	372 1.6×	75	1.3k
Manuel N. Fernández Spain	12	1.2k 1.1×	649 1.1×	392 1.0×	237 0.7×	160 0.7×	17	1.4k

Countries citing papers authored by Mary Laughlin

Since Specialization

Citations

This map shows the geographic impact of Mary Laughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Laughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Laughlin more than expected).

Fields of papers citing papers by Mary Laughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Laughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Laughlin. The network helps show where Mary Laughlin may publish in the future.

Co-authorship network of co-authors of Mary Laughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Laughlin. A scholar is included among the top collaborators of Mary Laughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Laughlin. Mary Laughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laughlin, Mary, et al.. (2025). “Heart-sink patients”: Attitudes of mental health professionals toward individuals with a diagnosis of borderline personality disorder—A qualitative evidence synthesis.. Stigma and Health.

Laughlin, Mary, et al.. (2020). COVID-19 and Its Impact on Collection and Processing of Cord Blood Units at the Cleveland Cord Blood Center. Stem Cells Translational Medicine. 9(S1). S18–S18. 1 indexed citations

Laughlin, Mary, et al.. (2018). Antimicrobial and wound healing properties associated with umbilical cord derived monocytes and platelet rich plasma. Cytotherapy. 20(5). S109–S109. 2 indexed citations

Laughlin, Mary, et al.. (2017). Affect Matters: When Writing Feedback Leads to Negative Feeling. SHILAP Revista de lepidopterología. 11(2). 11 indexed citations

Ramanathan, Muthalagu, Pierre Teira, Minoo Battiwalla, et al.. (2016). Impact of early CMV reactivation in cord blood stem cell recipients in the current era. Bone Marrow Transplantation. 51(8). 1113–1120. 32 indexed citations

Spellman, Stephen R., Carolyn Katovich Hurley, Colleen A. Brady, et al.. (2011). Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood. Cytotherapy. 13(7). 848–855. 23 indexed citations

Laughlin, Mary, Joanne Kurtzberg, John D. McMannis, & Lawrence D. Petz. (2010). Eighth Annual International Umbilical Cord Blood Transplantation Symposium, San Francisco, California, June 3-5, 2010. Biology of Blood and Marrow Transplantation. 17(2). 176–189. 1 indexed citations

Wagner, John E., Mary Laughlin, & Lawrence D. Petz. (2009). Seventh Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, June 5-6, 2009. Biology of Blood and Marrow Transplantation. 16(1). 12–27. 7 indexed citations

Laughlin, Mary. (2008). "Pharming" endangers teens.. PubMed. 101(6-7). 164–164. 1 indexed citations

10.

Eapen, Mary, Vanderson Rocha, Andromachi Scaradavou, et al.. (2008). Effect of Stem Cell Source on Transplant Outcomes in Adults with Acute Leukemia: A Comparison of Unrelated Bone Marrow (BM), Peripheral Blood (PB) and Cord Blood (CB). Blood. 112(11). 151–151. 10 indexed citations

11.

Wagner, John E., Claudio G. Brunstein, William Ka Fai Tse, & Mary Laughlin. (2008). Umbilical Cord Blood Transplantation. Cancer treatment and research. 144. 233–255. 5 indexed citations

12.

Barr, Paul M., Pingfu Fu, Hillard M. Lazarus, et al.. (2007). Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia. Leukemia & lymphoma. 48(10). 1940–1949. 14 indexed citations

13.

Robertson, Michael J., Brad S. Kahl, Julie M. Vose, et al.. (2007). Phase II Study of Enzastaurin, a Protein Kinase C Beta Inhibitor, in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology. 25(13). 1741–1746. 196 indexed citations

14.

Wall, Donna A., Elizabeth L. Wagner, Shelly L. Carter, et al.. (2005). Post-Thaw Colony Forming Unit (CFU) Counts and Yield Are the Most Important Predictors of Engraftment and Survival Following Unrelated Donor Cord Blood Transplantation (CBT): A COBLT Study Report.. Blood. 106(11). 2046–2046. 1 indexed citations

15.

Cornetta, Kenneth, Mary Laughlin, Shelly Carter, et al.. (2005). Umbilical cord blood transplantation in adults: Results of the prospective cord blood transplantation (COBLT). Biology of Blood and Marrow Transplantation. 11(2). 149–160. 103 indexed citations

16.

Long, Gwynn D., Mary Laughlin, Bella Madan, et al.. (2003). Unrelated umbilical cord blood transplantation in adult patients. Biology of Blood and Marrow Transplantation. 9(12). 772–780. 100 indexed citations

17.

Koç, Omer N., Stanton L. Gerson, Brenda Cooper, et al.. (2000). Randomized Cross-Over Trial of Progenitor-Cell Mobilization: High-Dose Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor (G-CSF) Versus Granulocyte-Macrophage Colony-Stimulating Factor Plus G-CSF. Journal of Clinical Oncology. 18(9). 1824–1830. 72 indexed citations

18.

Crump, M., Peter Rubin, Maureen Ross, et al.. (1997). A phase I trial of recombinant human interleukin-1β(OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplantation. 19(4). 315–322. 13 indexed citations

19.

Kurtzberg, Joanne, Mary Laughlin, Michael L. Graham, et al.. (1997). Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation Into Unrelated Recipients. Obstetrical & Gynecological Survey. 52(1). 22–23. 71 indexed citations

20.

Kurtzberg, Joanne, Mary Laughlin, Michael L. Graham, et al.. (1996). Placental Blood as a Source of Hematopoietic Stem Cells for Transplantation into Unrelated Recipients. New England Journal of Medicine. 335(3). 157–166. 762 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact